首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal JPT1 Antibody

  • 中文名: JPT1抗体
  • 别    名: HN1; ARM2; HN1A
货号: IPDX10010
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/40-1/200 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/5000-1/10000 Human,Mouse,Rat

产品详情

AliasesHN1; ARM2; HN1A
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenFusion protein of human JPT1
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是关于JPT1抗体的3篇代表性文献的简要总结(注:文献为示例性内容,实际引用需核实):

1. **文献名称**: *JPT1 promotes colorectal cancer progression via Wnt/β-catenin signaling*

**作者**: Li X, et al. (2020)

**摘要**: 研究揭示JPT1在结直肠癌中高表达,通过激活Wnt/β-catenin通路促进肿瘤细胞增殖和迁移。实验中使用JPT1抗体进行免疫组化,证实其与患者预后不良相关。

2. **文献名称**: *JPT1 interacts with ATM/ATR to regulate DNA damage response*

**作者**: Zhang Y, et al. (2018)

**摘要**: 发现JPT1通过结合DNA损伤激酶ATM/ATR,调控细胞周期检查点。利用JPT1抗体敲低蛋白表达后,细胞对辐射敏感性显著增加,提示其作为潜在治疗靶点。

3. **文献名称**: *Development of a monoclonal JPT1 antibody for targeted cancer therapy*

**作者**: Chen H, et al. (2021)

**摘要**: 报道一种新型抗JPT1单克隆抗体的开发,该抗体在体外抑制肿瘤细胞侵袭,并在小鼠模型中显著减小移植瘤体积,机制涉及下游PI3K/AKT通路抑制。

---

*注:以上文献信息为模拟示例,实际研究中需通过PubMed、Web of Science等平台以“JPT1 antibody”或“JPT1 function”为关键词检索真实文献。*

背景信息

The JPT1 antibody is a research tool designed to target the JADE1 (Jade family PHD zinc finger 1) protein, a component of the HBO1 (histone acetyltransferase binding to ORC1) complex. JADE1 is implicated in epigenetic regulation, particularly through histone H4 acetylation, which influences chromatin remodeling, gene transcription, and DNA repair. It plays roles in cell cycle progression, apoptosis, and organogenesis, with links to cancers, polycystic kidney disease, and hypoxia responses. The JPT1 antibody, often used in techniques like Western blotting, immunoprecipitation, and immunofluorescence, helps elucidate JADE1’s interaction networks and its regulatory mechanisms in development and disease. Studies using this antibody have highlighted JADE1’s tumor-suppressive functions and its role in modulating Wnt/β-catenin signaling. Researchers rely on JPT1 to investigate how JADE1 dysfunction contributes to pathological states, offering insights into therapeutic targeting of epigenetic pathways. Validation specifics (e.g., species reactivity, applications) vary by commercial source, requiring careful experimental optimization.

客户数据及评论

折叠内容

大包装询价

×